148 related articles for article (PubMed ID: 29352447)
21. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors.
Duffner PK
Neurologist; 2004 Nov; 10(6):293-310. PubMed ID: 15518596
[TBL] [Abstract][Full Text] [Related]
22. [Endocrinological outcome in children and adolescents survivors of central nervous system tumours after a 5 year follow-up].
Güemes Hidalgo M; Muñoz Calvo MT; Fuente Blanco L; Villalba Castaño C; Martos Moreno GA; Argente J
An Pediatr (Barc); 2014 Jun; 80(6):357-64. PubMed ID: 24103246
[TBL] [Abstract][Full Text] [Related]
23. Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy.
Odagiri K; Omura M; Hata M; Aida N; Niwa T; Ogino I; Kigasawa H; Ito S; Adachi M; Inoue T
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):632-8. PubMed ID: 22420962
[TBL] [Abstract][Full Text] [Related]
24. Endocrine manifestations of central nervous system germ cell tumors in children.
García García E; Gómez Gila AL; Merchante E; Rivero Garvia M; Venegas Moreno E; Soto Moreno A; Márquez Vega C
Endocrinol Diabetes Nutr (Engl Ed); 2020 Oct; 67(8):540-544. PubMed ID: 32197991
[TBL] [Abstract][Full Text] [Related]
25. Childhood Craniopharyngioma: A 22-Year Challenging Follow-Up in a Single Center.
Tosta-Hernandez PDC; Siviero-Miachon AA; da Silva NS; Cappellano A; Pinheiro MM; Spinola-Castro AM
Horm Metab Res; 2018 Sep; 50(9):675-682. PubMed ID: 29959763
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and Risk Factors for Endocrine Disorders in Childhood Brain Tumors From a Single Tertiary Center in Malaysia.
Ng YJ; Jalaludin MY; Foo JC; Qaddoumi I; Rajagopal R
J Pediatr Hematol Oncol; 2022 May; 44(4):159-166. PubMed ID: 35446802
[TBL] [Abstract][Full Text] [Related]
27. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
28. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.
Di Battista E; Naselli A; Queirolo S; Gallarotti F; Garré ML; Milanaccio C; Cama A
J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():431-7. PubMed ID: 16700321
[TBL] [Abstract][Full Text] [Related]
29. Body mass index and hypothalamic morphology on MRI in children with congenital midline cerebral abnormalities.
Traggiai C; Stanhope R
J Pediatr Endocrinol Metab; 2004 Feb; 17(2):219-21. PubMed ID: 15055357
[TBL] [Abstract][Full Text] [Related]
30. Early and late endocrine effects in pediatric central nervous system diseases.
Aslan IR; Cheung CC
J Pediatr Rehabil Med; 2014; 7(4):281-94. PubMed ID: 25547881
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Effect of Cranial Radiotherapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors.
Follin C; Erfurth EM
Curr Treat Options Oncol; 2016 Sep; 17(9):50. PubMed ID: 27476159
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and risk factors of hypothalamic-pituitary dysfunction in infant and toddler childhood brain tumor survivors.
Lebbink CA; Ringers TP; Schouten-van Meeteren AYN; van Iersel L; Clement SC; Boot AM; Claahsen-van der Grinten HL; Janssens GO; van Vuurden DG; Michiels EM; Han KS; van Trotsenburg ASP; Vandertop WP; Kremer LCM; van Santen HM
Eur J Endocrinol; 2021 Sep; 185(4):597-606. PubMed ID: 34324432
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of centrally located low-grade glioma in children.
Terashima K; Chow K; Jones J; Ahern C; Jo E; Ellezam B; Paulino AC; Okcu MF; Su J; Adesina A; Mahajan A; Dauser R; Whitehead W; Lau C; Chintagumpala M
Cancer; 2013 Jul; 119(14):2630-8. PubMed ID: 23625612
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for the development of obesity in children surviving brain tumors.
Lustig RH; Post SR; Srivannaboon K; Rose SR; Danish RK; Burghen GA; Xiong X; Wu S; Merchant TE
J Clin Endocrinol Metab; 2003 Feb; 88(2):611-6. PubMed ID: 12574189
[TBL] [Abstract][Full Text] [Related]
35. Endocrine diagnosis and treatment of sellar lesions in pediatric age.
García-García E; González-Aguilera B; Gros N; Romero-Lluch A; Jiménez-Varo I; Martínez-Ortega AJ; Aliaga-Verdugo A
Endocrinol Nutr; 2014; 61(7):359-65. PubMed ID: 24636866
[TBL] [Abstract][Full Text] [Related]
36. Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma.
Chakrabarti I; Amar AP; Couldwell W; Weiss MH
J Neurosurg; 2005 Apr; 102(4):650-7. PubMed ID: 15871507
[TBL] [Abstract][Full Text] [Related]
37. [Optic chiasm glioma in children: Endocrine disorders in 14 cases].
García García E; Márquez Vega C; Fajardo Cascos M; Venegas Moreno E; Soto Moreno A
Med Clin (Barc); 2016 May; 146(10):446-9. PubMed ID: 26971985
[TBL] [Abstract][Full Text] [Related]
38. Thalamic and hypothalamic tumors of childhood: endocrine late effects.
Oberfield SE; Garvin JH
Pediatr Neurosurg; 2000 May; 32(5):264-71. PubMed ID: 10965274
[TBL] [Abstract][Full Text] [Related]
39. Pituitary disease in pediatric brain tumor survivors.
Howell JC; Rose SR
Expert Rev Endocrinol Metab; 2019 Jul; 14(4):283-291. PubMed ID: 31131647
[TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction.
Adams LA; Feldstein A; Lindor KD; Angulo P
Hepatology; 2004 Apr; 39(4):909-14. PubMed ID: 15057893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
